Docosapolyenoic fatty acids and human endothelial cells

Area of Science:

• Biochemistry
• Cell Biology
• Lipid Metabolism

Background:

• Human endothelial cells contain specific docosaenoic fatty acids like 22:4(n-6), 22:5(n-3), and 22:6(n-3).
• Arachidonic acid (20:4(n-6)) is a key precursor for inflammatory mediators in endothelial cells.

Purpose of the Study:

• To investigate the impact of specific docosaenoic fatty acids on endothelial cell lipid composition.
• To determine the effect of these fatty acids on prostacyclin (prostaglandin I2) synthesis.

Main Methods:

• Primary human endothelial cell monolayers were cultured.
• Cells were incubated with docosaenoic fatty acids (22:4(n-6), 22:5(n-6), 22:6(n-3)) bound to albumin.
• Lipid composition and prostacyclin synthesis (measured as 6-ketoprostaglandin F1 alpha) were analyzed.

Main Results:

• Docosaenoic fatty acids were incorporated into endothelial cell phospholipids.
• Incubation with these fatty acids reduced endogenous arachidonic acid (20:4(n-6)) levels in phospholipids.
• Prostacyclin synthesis was significantly decreased by 22:4(n-6), 22:5(n-6), and 22:5(n-3).
• The reduction in arachidonic acid and prostacyclin synthesis was reversed by co-incubation with arachidonic acid.

Conclusions:

• Docosaenoic fatty acids from both (n-6) and (n-3) families are incorporated into endothelial cells.
• Incorporation of these fatty acids leads to a decrease in cellular arachidonic acid.
• These docosaenoic fatty acids inhibit prostacyclin synthesis in endothelial cells.